Nathan Brinkman has over 25 years of experience in the plasma-based pharmaceutical industry, particularly at CSL Behring, where current roles include Director and Associate Director of Breakthrough Technologies and Plasma Protein Research Support. Brinkman leads multidisciplinary teams in developing innovative technologies, spearheads global innovation strategies, and manages project portfolios to align with business objectives. Previous roles encompass positions such as Sr. Manager of New Plasma Protein Development and Sr. Scientist, focusing on process optimization, technical transfer, and purification process development. Educational qualifications include a Bachelor of Science in Clinical Laboratory Science from the University of Illinois Springfield and an MBA from Olivet Nazarene University.
This person is not in any teams
This person is not in any offices